Table 3.
Eye with NVG | ||||||
---|---|---|---|---|---|---|
OD | OS | Total | ||||
Th: with AVGF | N | % | N | % | N | % |
Avastin ® (Bevacizumab) | 33 | 67.3 | 36 | 72.0 | 69 | 69.7 |
Macugen ® (Pegaptanib sodium) | 5 | 10.2 | 4 | 8.0 | 9 | 9.1 |
Lucentis ® (Ranibizumab) | 8 | 16.3 | 8 | 16.0 | 16 | 16.2 |
5 – FU ® (5-fluorouracil) | 3 | 6.1 | 2 | 4.0 | 5 | 5.1 |
Total | 49 | 100.0 | 50 | 100.0 | 99 | 100.0 |